Skip to main content

Table 3 Power (%) of seven methods to detect association of rare variants under seven scenarios for underlying genetic architecture using data simulated for TERT in 2000 cases and 2000 controls

From: The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

  

Threshold for significance

  

P < 0.001

P < 0.01

P < 0.05

Scenario*

Proportion of variants associated

RAML

SKAT-O

T1

T5

WST

VTT

EREC

RAML

SKAT-O

T1

T5

WST

VTT

EREC

RAML

SKAT-O

T1

T5

WST

VTT

EREC

1

0.05

15.5

10.5

3.5

4.0

4.0

6.5

10.5

34.0

22.5

14.0

16.0

14.5

15.0

20.5

48.5

36.0

25.5

22.5

24.0

30.0

34.0

2

0.05

19.5

13.0

5.0

4.0

3.5

7.0

13.5

28.5

21.5

11.5

11.0

12.0

14.5

19.0

42.5

38.5

24.0

21.5

24.0

25.0

36.5

3

0.05

18.0

10.5

6.5

4.5

3.5

5.5

6.5

33.5

17.5

12.5

7.0

11.0

12.0

18.5

47.0

35.5

26.0

18.0

25.0

25.5

33.5

4

0.05

13.0

5.0

2.0

1.0

1.0

1.0

3.0

22.5

13.5

7.0

4.0

5.0

6.0

9.0

38.5

27.5

14.0

14.5

14.5

12.5

25.5

5

0.05

21.5

13.5

4.5

4.5

3.0

6.0

9.0

32.5

21.0

10.0

8.5

9.0

14.0

17.5

49.0

35.5

19.5

20.0

20.0

20.5

36.5

6

0.05

15.0

8.5

3.0

4.0

2.0

5.0

6.5

26.5

13.5

7.5

7.0

7.0

10.0

12.0

39.0

25.0

16.5

12.5

13.5

15.5

22.0

7

0.05

10.5

4.5

0.0

2.0

1.5

2.5

4.5

24.0

10.5

3.0

7.5

4.0

4.5

10.0

38.5

25.0

11.0

13.0

10.5

16.0

22.5

1

0.10

23.0

18.5

12.5

15.0

13.0

16.0

19.0

41.0

32.0

26.0

24.5

27.5

31.0

34.0

63.0

51.0

43.5

39.5

48.0

44.0

53.5

2

0.10

14.5

9.0

7.0

3.5

5.0

7.0

7.5

25.0

20.5

15.5

8.0

12.0

13.0

19.5

42.5

36.0

23.5

23.5

24.0

25.0

34.0

3

0.10

17.5

11.5

6.5

6.5

7.0

8.5

10.5

33.0

23.5

19.5

14.5

18.5

22.0

22.0

47.5

39.0

33.0

27.0

33.5

32.5

39.5

4

0.10

10.5

10.0

4.5

5.5

4.5

5.0

7.5

24.5

18.0

11.0

11.0

10.5

12.0

16.5

42.5

32.5

20.0

21.0

20.5

22.5

34.0

5

0.10

12.5

11.0

3.5

6.0

5.5

5.5

10.0

27.0

20.0

10.5

14.0

11.0

13.0

22.5

39.5

35.5

28.0

27.0

23.5

26.0

34.5

6

0.10

6.5

6.0

3.0

0.0

2.0

2.5

4.5

23.0

14.0

7.0

6.5

6.0

7.5

12.5

40.0

27.5

17.0

13.5

17.0

18.5

26.0

7

0.10

10.5

7.0

2.0

0.5

2.0

2.0

6.0

21.0

15.0

5.5

7.5

7.0

6.5

12.5

35.5

25.5

13.5

14.0

13.5

16.0

24.0

1

0.20

31.0

33.5

31.5

24.5

30.5

30.5

30.5

55.0

58.0

53.0

48.5

61.0

55.5

58.5

75.0

72.0

73.5

67.5

75.5

70.5

73.0

2

0.20

12.5

12.0

9.5

6.5

9.5

10.0

12.5

34.0

30.5

25.0

20.0

26.0

26.0

29.5

63.5

53.5

45.5

37.0

45.0

42.0

55.0

3

0.20

18.0

14.5

11.0

11.0

14.5

15.5

16.0

39.0

36.5

32.0

23.5

33.0

31.5

35.0

58.5

58.5

49.5

45.0

49.5

45.5

56.5

4

0.20

12.5

10.5

5.5

3.0

3.0

4.5

7.5

23.5

18.5

16.0

16.0

16.0

17.5

20.0

46.0

40.5

31.5

28.5

31.5

31.0

39.0

5

0.20

14.5

10.5

6.5

4.5

5.0

6.5

10.5

28.5

27.0

20.0

17.5

19.0

17.5

26.5

48.5

47.0

36.5

30.0

32.5

36.0

43.0

6

0.20

11.5

6.0

2.0

3.0

1.0

2.0

4.0

27.0

15.5

7.0

7.5

8.0

8.0

17.5

43.0

38.0

19.5

21.0

20.0

21.5

33.5

7

0.20

9.5

4.0

1.0

2.0

1.0

1.0

4.5

22.0

17.5

5.5

5.5

6.0

5.5

13.0

44.5

30.0

15.0

13.0

11.5

17.5

28.5

  1. Method with greatest power emboldened.
  2. * See text for description of genetic architecture for each scenario.
  3. RAML Rare admixture maximum likelihood, SKAT-O sequence kernel association test, T1 fixed threshold test 1 per cent MAF, T5 fixed threshold test 5 per cent MAF, WST weighted sum test, VTT variable threshold test, EREC estimated regression coefficient test.